QUEST informs readers of the latest advances in urologic prostate cancer research, especially detection, prevention, and treatment.
The study investigated how body mass index (BMI) relates to prostate cancer screening results, incidence, and mortality among men participating in the Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial. This trial included 36,756 men who were regularly screened…
A recent study explored how brief, intense bursts of physical activity, called vigorous intermittent lifestyle physical activity (VILPA), relate to cancer risk. The study followed more than 22,000 adults who did not regularly exercise. Participants wore accelerometers on their wrists…
Obesity is a global epidemic and contributes to increasing mortality rates. Obesity is one of the top five risk factors for mortality and was associated with approximately 5 million deaths worldwide in 2019. Generally, obesity is determined by body mass…
Often reclassification to Grade Group 2 from Grade Group 1 prostate cancer results in men leaving active surveillance. To date, there has been limited data available to guide this decision making. This study aimed to identify subgroups of men who…
This study examined the association of extraprostatic tumor extension (EPE) with biochemical recurrence (BCR) separately in men with Grade Group (GG)1 and Grade Group (GG)2 prostate cancer treated with radical prostatectomy. After review of patient records, a cohort of 6309…
The Veterans Choice Program (VCP), implemented in 2014, aimed to help veterans with prostate cancer get specialized care outside of Veterans Health Administration (VHA) facilities. This study examined how many veterans used this program and what kind of care they…
Researchers reported differences in the risk of early prostate cancer death among men with higher vs lower genetic risk. They performed a combined analysis with a 20-year follow-up of genotyped men without prostate cancer in 2 prospective cohort studies including…
Between 1999 and 2009 in the United Kingdom, 82,429 men between 50 and 69 years of age received a PSA test. After 15 years of follow-up, prostate cancer-specific mortality was low in this cohort of men in the UK with…
Plant-based diets are associated with many benefits, including primary prevention of fatal prostate cancer. Less is known about post-diagnostic plant-based diet patterns in individuals with prostate cancer. This longitudinal observational cohort study included men with nonmetastatic prostate cancer. Data from…
Listen to the music. Dr. Catalona reflected upon his memory of one of his late patients and a member of the URF Board, Mr. Julius (Jules) Reichel, and his beloved grandson, Benjamin Sokol, who is now a rising star in…
"*" indicates required fields
